Search
for

    Sort by

    Research 211–240 of 1000+

    1. Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial Scientific Reports · 2025 · 3 citations
    2. Editorial: Crosstalk: skin cells and immune cells in inflammatory skin diseases Frontiers in Immunology · 2024 · 3 citations
    3. Manifestaciones clínicas y complicaciones de la enfermedad por coronavirus 2019 (COVID-19): revisión de la literatura Ciencia Tecnologí­a y Salud · 2020 · 3 citations
    4. Transnasal cooling: A Pandora’s box of transnasal patho-physiology Medical Hypotheses · 2011 · 3 citations
    5. Discovery of New Drug Therapies Based on the Study of Adverse Reactions Drug Information Journal · 1989 · 3 citations
    6. Optical Coherence Tomography Angiography Findings in Polycystic Ovary Syndrome JCPSP. Journal of the College of Physicians & Surgeons Pakistan · 2021 · 2 citations
    7. Chemotherapy-induced alopecia: A novel observation Australasian Journal of Dermatology · 2018 · 2 citations
    8. MORPHOLOGICAL STUDIES ON THE LIPS OF BUFFALO Kafrelsheikh Veterinary Medical Journal · 2007 · 2 citations
    9. Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program American Journal of Clinical Dermatology · 2025 · 1 citations
    10. 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study Journal of the American Academy of Dermatology · 2023 · 1 citations
    11. Safety and Efficacy of Oral administrated Cepharanthine in Non-hospitalized, asymptomatic or mild COVID-19 patients: A Double-blind, Randomized, Placebo-controlled Trial bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 1 citations
    12. ОСТРЫЙ ПОСТОПЕРАЦИОННЫЙ БОЛЕВОЙ СИНДРОМ У ПАЦИЕНТОВ РИНОХИРУРГИЧЕСКОГО ПРОФИЛЯ ПОСЛЕ ИСПОЛЬЗОВАНИЯ ПОПУЛЯРНЫХ МЕТОДОВ АНЕСТЕЗИИ В Г. МОСКВЕ. Голова и шея. · 2022 · 1 citations
    13. Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto Open Repository of the University of Porto (University of Porto) · 2025
    14. Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto Open Repository of the University of Porto (University of Porto) · 2024
    15. O plasma rico em plaquetas e sua utilização na estética LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 2024
    16. Serum Vitamin C Response to Daily Supplementation in a Zero-Carb Adult: An N=1 Case Study Zenodo (CERN European Organization for Nuclear Research) · 2026
    17. Serum Vitamin C Response to Daily Supplementation in a Zero-Carb Adult: An N=1 Case Study Zenodo (CERN European Organization for Nuclear Research) · 2026
    18. “Bioprinting of Hair: How Far We Proceeded and What Needs to be Done” Biotechnology and Bioengineering · 2026
    19. Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older Actas Dermo-Sifiliográficas · 2025
    20. Reviving Hair Naturally: An Ayurvedic Case Report on Indralupta (Alopecia) Journal of Integrated Health Sciences · 2025
    21. Evaluation of Retinal Changes in Women with Different Phenotypes of Polycystic Ovary Syndrome Diagnostics · 2025
    22. Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials 2025
    23. Novel investigational drugs for alopecia areata and future perspectives Expert opinion on investigational drugs · 2024
    24. Viola odorata L. 2024
    25. Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2 Journal of the European Academy of Dermatology and Venereology · 2024
    26. Premature graying of hairs: Ayurveda perspective Journal of Indian System of Medicine · 2023
    27. 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    28. Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study SKIN The Journal of Cutaneous Medicine · 2023
    29. Evaluation of Retinal Layers and Choroidal Structures Using Optical Coherence Tomography in Alopecia Areata Medeniyet medical journal · 2023
    30. 752 Diet and the dermal white adipose tissue: Analyzing shifts in the cutaneous lipid landscape in response to dietary change 2020